Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on: January 11,2024 15

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on:January 11,2024 15

ASCO: undertreatment seen for women with head and neck cancer

(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, accordi

Updated on: March 30,2024 12

ASCO: undertreatment seen for women with head and neck cancer

(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, accordi

Updated on:March 30,2024 12

Studies expand and update an encyclopedia of cancer cell lines

by Tom Ulrich,Broad Institute of MIT and HarvardCredit : Susanna M. Hamilton, Broad CommunicationsLarge libraries of cancer cell lines—collections of cells that represent tumor types seen in can

Updated on: June 28,2024 5

Studies expand and update an encyclopedia of cancer cell lines

by Tom Ulrich,Broad Institute of MIT and HarvardCredit : Susanna M. Hamilton, Broad CommunicationsLarge libraries of cancer cell lines—collections of cells that represent tumor types seen in can

Updated on:June 28,2024 5

Study sheds light on the function of a long-mysterious PCSK9 mutation

by American Society for Biochemistry and Molecular BiologyCredit: CC0 Public DomainHigh levels of low-density lipoproteins, parcels of lipids and protein that carry cholesterol, are a leading ris

Updated on: April 18,2024 18

Study sheds light on the function of a long-mysterious PCSK9 mutation

by American Society for Biochemistry and Molecular BiologyCredit: CC0 Public DomainHigh levels of low-density lipoproteins, parcels of lipids and protein that carry cholesterol, are a leading ris

Updated on:April 18,2024 18

Study connects research scientists with the communities they serve

by Mark Anthony Febbo,University of ArizonaJoann Sweasy, PhD, director of the UArizona Cancer Center, speaks at a Scientific Café event at Rollies Mexican Patio restaurant. Credit: UArizona Heal

Updated on: February 23,2024 17

Study connects research scientists with the communities they serve

by Mark Anthony Febbo,University of ArizonaJoann Sweasy, PhD, director of the UArizona Cancer Center, speaks at a Scientific Café event at Rollies Mexican Patio restaurant. Credit: UArizona Heal

Updated on:February 23,2024 17

Cervical pre-cancer can be detected in self-collected urine or vaginal sample

by Chris Mahony,Queen Mary, University of LondonCredit: CC0 Public DomainQueen Mary University of London researchers have developed a non-invasive test to detect cervical pre-cancer by analyzing

Updated on: March 06,2024 20

Cervical pre-cancer can be detected in self-collected urine or vaginal sample

by Chris Mahony,Queen Mary, University of LondonCredit: CC0 Public DomainQueen Mary University of London researchers have developed a non-invasive test to detect cervical pre-cancer by analyzing

Updated on:March 06,2024 20

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

Updated on: April 14,2024 14

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

Updated on:April 14,2024 14

Boosting T cell 'memory' may result in longer-lasting and effective responses for patients

by University of Texas M. D. Anderson Cancer CenterScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDJust like pe

Updated on: April 18,2024 11

Boosting T cell 'memory' may result in longer-lasting and effective responses for patients

by University of Texas M. D. Anderson Cancer CenterScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDJust like pe

Updated on:April 18,2024 11

An unexpected journey reveals a potent way to attack tumors

by Nancy Fliesler,Children's Hospital BostonSenescence inducer CuSO4, which causes ER stress, activates NKp46- and NKG2D-dependent NK killing, but 4-PBA, which induces senescence without ER

Updated on: February 23,2024 13

An unexpected journey reveals a potent way to attack tumors

by Nancy Fliesler,Children's Hospital BostonSenescence inducer CuSO4, which causes ER stress, activates NKp46- and NKG2D-dependent NK killing, but 4-PBA, which induces senescence without ER

Updated on:February 23,2024 13

Team discovers secret to making immune cells better cancer killers

by University of VirginiaResearchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their finding could allow doctors to make the

Updated on: May 27,2024 6

Team discovers secret to making immune cells better cancer killers

by University of VirginiaResearchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their finding could allow doctors to make the

Updated on:May 27,2024 6

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord

Updated on: January 30,2024 18

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord

Updated on:January 30,2024 18

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on: January 02,2024 8

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on:January 02,2024 8